ObsEva appoints Annette Clancy as Chair of its Board of Directors

– SWITZERLAND, Geneva –  ObsEva SA ( SIX: OBSN | NASDAQ: OBSV), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the appointment of Annette Clancy as Chair of the Board of Directors on May 18, 2022, succeeding Dr.…

ObsEva nominates Stephanie Brown for election to its Board of Directors

– SWITZERLAND, Geneva –  ObsEva SA (SIX: OBSN | NASDAQ: OBSV), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the nomination of Stephanie Brown for election to its Board of Directors at the 2022 AGM, bringing valuable commercial expertise and industry insight to the Board.…

ObsEva nominates Anne VanLent for election to its Board of Directors

– SWITZERLAND, Geneva –  ObsEva SA (SIX: OBSN |NASDAQ: OBSV), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the nomination of Anne VanLent for her election to its Board of Directors at the 2021 AGM to be held on May 28, 2021.…